Min Meng
- Parasitology top 5%
- Toxoplasma gondii Research Studies 5
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Cancer Research top 10%
-
- Lung Cancer Diagnosis and Treatment 19
- Lung Cancer Treatments and Mutations 15
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 9
- Medical Imaging and Pathology Studies 8
- Oncology top 10%
- Lung Cancer Research Studies 8
-
- Herpesvirus Infections and Treatments 5
- Journals
- International Journal of Hyperthermia (9 papers)European Radiology (6 papers)BMC Infectious Diseases (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Min Meng
99 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 131
- Parasitology 170
- Hepatology 167
- Cancer Research 247
- Pulmonary and Respiratory Medicine 528
- Oncology 387
Countries citing papers authored by Min Meng
This map shows the geographic impact of Min Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Meng more than expected).
Fields of papers citing papers by Min Meng
This network shows the impact of papers produced by Min Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Meng. The network helps show where Min Meng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 82 | |
| 7 | 2021 | 34 | |
| 8 | 2020 | 133 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 20 | |
| 11 | 2018 | 34 | |
| 12 | 2018 | 77 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 12 | |
| 15 | 2015 | 40 | |
| 16 | 2013 | 39 | |
| 17 | 2012 | 68 | |
| 18 | 2012 | 7 | |
| 19 | 2011 | 4 | |
| 20 | 2005 | 50 |
About Min Meng
Min Meng is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Parasitology and Cancer Research, having authored 99 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Medical Imaging and Pathology Studies (8 papers), Lung Cancer Research Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Herpesvirus Infections and Treatments (5 papers) and Toxoplasma gondii Research Studies (5 papers). The work is most often cited by research in Parasitology (170 citations), Hepatology (167 citations), Cancer Research (247 citations), Pulmonary and Respiratory Medicine (528 citations) and Oncology (387 citations). Min Meng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guanghui Huang, Xiaoying Han, Yang Ni, Zhigang Wei, Wenhong Li, Xin Ye, Xia Yang, Jiao Wang, H. Benjamin Peng and Chunling Wang. Their work appears in journals such as International Journal of Hyperthermia, European Radiology, BMC Infectious Diseases, Journal of Cancer Research and Clinical Oncology and Journal of Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.